By Jakobe Gilbert

Fact-checked by Reese Foster against vendor lab documentation and published research. 

Last updated July 2026.

Retatrutide peptide for sale appears on many research-supply sites, and this guide explains everything you need to know about it. You will learn what retatrutide is, what published trials found, whether it is legal, what it costs, and where to buy research-grade retatrutide. Our pick for a clearly labeled, lab-tested source for research-grade retatrutide is Kylo Peptides.

Please keep in mind that all the information here is for laboratory research only. Retatrutide is investigational, meaning it is still in testing and not sold for human use. 

What Is Retatrutide (LY3437943)?

Retatrutide is an experimental peptide, known by the code name LY3437943. It is a single lab-made molecule that acts on three receptors at once: GIP, GLP-1, and glucagon. Scientists study it primarily for its effects on metabolism and body weight.

A peptide is just a short chain of amino acids, the same building blocks that make up proteins. Retatrutide is designed to mimic the actions of natural gut and pancreatic hormones. That design is why researchers group it with the newer metabolic peptides.

It was developed by the drugmaker Eli Lilly, and its first large-scale human results were published in the New England Journal of Medicine in 2023. As of 2026, it is still investigational. No health authority has approved it as a medicine.

Because it is not an approved drug, the retatrutide sold online is supplied as a research compound. It comes as a freeze-dried powder, called a lyophilized powder, that a lab dissolves before any study.

• Type: synthetic peptide (a triple receptor agonist).
• Code name: LY3437943.
• Developer: Eli Lilly.
• Status: investigational, not an approved medicine.
• Available as: A research-use-only compound, not for human use.

How Does Retatrutide Work?

Retatrutide works by acting like three natural hormones simultaneously. In research models, it activates the GIP, GLP-1, and glucagon receptors simultaneously. That triple action is what sets it one step ahead of older peptides that target only one or two of these targets.

Here is what each target is linked to in research:

• GLP-1 receptor: In studies, GLP-1 signaling is tied to feeling full and to steadier blood sugar, which is why GLP-1 peptides are so widely researched.
• GIP receptor: GIP works alongside GLP-1 and also relates to how the body handles sugar and fat, so hitting both may add to the effect.
• Glucagon receptor: Glucagon is linked to how the body burns stored energy, and adding this third target is the main thing that sets retatrutide apart.
• Why three at once: Combining the targets is the whole point of retatrutide, and it is what researchers test against single-target and dual-target peptides.

Researchers are interested in this mix because hitting all three pathways at once may have a bigger effect in trials than hitting just one. The idea is that the three signals work together rather than alone. You can read the science behind these pathways through PubMed Central.

What Does Retatrutide Research Show So Far?

In its main published trial, retatrutide produced large reductions in body weight at the highest dose. The phase 2 study followed adults with obesity for 48 weeks. These are results from a controlled study, not outcomes promised to anyone who buys the research compound.

According to the published trial abstract, the 12 mg weekly group had an average body weight change of approximately -24.2%, compared with -2.1% for placebo. In that group, every participant lost at least 5% of body weight. About 93% lost at least 10%, and 83% lost at least 15%.

The trial measured body weight as its main outcome and carefully tracked several blood sugar markers along the way. The results were strong enough that retatrutide moved quickly into larger testing. That is why it is now one of the most-watched metabolic peptides in research.

Those are unusually large numbers for a metabolic trial, which is part of why retatrutide drew so much attention. Still, a single phase 2 study is not the final word. Bigger trials are needed to confirm the early results.

The compound is still being tested. Larger phase 3 trials, known as TRIUMPH, are underway and listed on ClinicalTrials.gov. Until those are finished and a regulator reviews them, retatrutide remains investigational.

• Trial phase: Phase 2, with a Phase 3 program ongoing.
• Length: 48 weeks.
• Top result: About -24.2% average body weight at 12 mg, versus -2.1% on placebo.

Retatrutide Dosages Used in Clinical Trials

The doses below are the amounts studied in clinical trials and are shared here as factual information only. This is not a dosing guide, and the research product is not for human use. In the phase 2 study, retatrutide was administered once weekly at four fixed dose levels.

The four tiers allow researchers to compare a low dose with higher doses within the same study. This is a standard way to learn how the response changes as the dose goes up. The highest tier, 12 mg, showed the largest average change.

Trials also used a slow step-up, starting at a low dose and rising over several weeks. Researchers do this to study how the body adjusts to a new compound over time. The step-up is part of the study design, not a recommendation.

Again, these figures describe a clinical study run under medical supervision. Nobody should read them as instructions, because research-grade retatrutide is sold for laboratory work only.

Retatrutide vs Tirzepatide and Semaglutide

Retatrutide, Tirzepatide, and semaglutide are all peptides studied for metabolism, but they don’t work the same way. The main differences are how many receptors each targets and whether it is approved. Retatrutide is the only one of the three that is still investigational.

In plain terms, semaglutide hits one target, Tirzepatide hits two, and retatrutide hits three. The two-target and one-target peptides are already approved and are also sold under brand names. Retatrutide is not, because it is still in trials.

You can check the approval status of Tirzepatide and semaglutide in the FDA drug database and find drug facts on MedlinePlus. 

For a researcher, the practical difference is access and proof. The approved peptides are made under strict drug-manufacturing rules and come with official paperwork. A research compound like retatrutide depends on the vendor’s own lab testing, which is why a certificate of analysis is so important.

How Retatrutide Is Supplied for Research?

Research-grade retatrutide is supplied as a sterile freeze-dried powder, called a lyophilized powder. A lab prepares it by adding a measured amount of bacteriostatic or sterile water, then letting it dissolve. This is general laboratory handling information for research use only, not guidance for any person.

1. The water is added slowly down the inside wall of the vial, not straight onto the powder.
2. The vial is swirled gently until the liquid is clear and is not shaken hard, which can damage the peptide.
3. The prepared solution is kept in a refrigerator, usually between two and eight degrees Celsius.
4. Unopened powder vials are stored frozen for longer, since the freeze-dried form is the most stable.

Good vendors ship the dry powder instead of a pre-mixed liquid because the dry form travels and stores better. The label should clearly state “research use only,” and the vial should match the certificate of analysis on the website. Some vendors also list it inside research blends with other peptides, but a single-compound vial is the simplest to verify against its certificate.

Why do Researchers Study Retatrutide?

Researchers study retatrutide mainly because of its triple action on metabolism. The areas of interest below are based on how the compound behaves in trials and lab models. These are open research questions, not benefits promised to anyone who buys the compound.

• Obesity research: The published trial focused on body-weight change in adults with obesity, which is the main area studied so far.
• Type 2 diabetes models: Because the peptide affects blood-sugar signaling, researchers also look at it in metabolic and diabetes-related research.
• Energy use: The glucagon target is tied to how the body burns stored energy, which is a separate research angle that two-target peptides do not cover. Background on obesity and metabolic research is available from the NIH.
• Comparison work: Because approved peptides like Tirzepatide already exist, researchers also study how a triple agonist stacks up against them in the same lab models.

These are the questions scientists are asking right now. None of this means the compound is ready for people, because it is still being tested in trials. The research is promising on paper, but promising is not the same as proven.

Is Retatrutide Legal to Buy? FDA and Research-Use Status

Retatrutide is legal to buy and sell in the United States only as a research chemical, provided it is properly labeled and sold for laboratory research use, not for human use. It is not approved by the FDA for any medical purpose. That single fact shapes how every honest vendor lists it.

Regulators are clear on this point. The FDA’s unapproved drugs page explains that products without approval cannot be sold for human use. FDA rules on compounding also keep pharmacies from making unapproved peptides like this one.

For a researcher, that means you can order it without a prescription as a research-use-only product. The line you cannot cross is selling it or using it on people. You can read more about how a drug actually becomes approved on the FDA’s drug-approval pages.

It also helps to keep good records. Researchers usually keep the certificate of analysis and the order details on file. That paperwork shows the material was bought and held as a research compound, not for personal use.

Where To Buy Retatrutide Peptide For Sale

Kylo Peptides is the safest place to buy research-grade reta online as it checks every batch twice. Reta is a long chain. Cheaper synthesis leaves broken, shorter pieces behind, and a single test can miss them. So we traced the process. We pulled our lot’s report, and both results matched to the decimal. Every vial we got was freshly manufactured, never old stock off a shelf. 

Pros

• Reta stocked across trial dose-tier sizes
• Membership: up to 50% lifetime off on repeat reta orders

Con

• Membership value only pays off on repeat orders

Kylo Labs LLC (Sheridan, WY) runs three independent testing rounds on every batch, in-house, then Janoshik (ISO/IEC 17025 accredited), then Freedom Diagnostics (ISO/IEC 17025 accredited) before a lot-matched COA is published to their public library. 

Their average HPLC-verified purity across lots sits at 99.61%, above the 99% floor most serious researchers treat as non-negotiable. 

Every lot also goes through endotoxin screening (USP <85>), sterility testing (USP <71>), and heavy metals analysis (ICP-MS), so the document trail covers more than just purity. 

Orders placed before 2 PM PST ship the same business day, with free shipping on US orders over $200. You can reach them at support@kylopeptides.com or +1 350-252-3314. 

How did We Review Retatrutide Sources and Research?

We built this guide by reading the published trials and by checking how vendors document their products. For sources, we looked for independent lab proof rather than marketing claims. We focused on what a careful researcher actually needs to see before buying.

• Lab proof: A recent third-party HPLC certificate of analysis (COA) showing about 99% purity, plus mass spectrometry to confirm identity. Testing standards, such as guidance on testing methods, are the benchmark.
• Form and labeling: A sterile lyophilized powder, clearly labeled “Research Use Only.”
• Transparency: US synthesis, clear shipping terms, and honest sourcing you can verify.

We treated any claim a vendor could not back up with a document as missing, and we left it out. Where a source posted lab reports, we opened them and read the purity figure ourselves.

How to Spot Quality Research-Grade Retatrutide?

When you compare retatrutide peptide, look for clear lab proof and honest labeling, and walk away from anything that hides its data. The checklist below is what separates a careful vendor from a risky one. None of this changes the fact that the product is for laboratory research only.

Here is what to demand from a vendor:

• A batch-specific COA: a recent certificate tied to your exact lot, dated and with a lot number, not a generic claim.
• Over 98% purity by HPLC, plus mass spectrometry to confirm the peptide’s identity.
• A sterile lyophilized powder, which stores better than a pre-mixed liquid.
• US synthesis and clear shipping terms you can read before checkout.
• Plain research-use-only labeling and an age check on the product page.

These are the warning signs that should stop a purchase:

• No COA, or a certificate with no date and no lot number.
• Any human dosing advice or medical claims, which the FTC’s health-claims guidance treats as a warning sign.
• Prices far below the normal range, which can mean weak or mislabeled material.
• No company address and vague answers from support.

It also helps to know the wider risk. The FDA tracks health-fraud products sold to consumers, so a quick check there can save you trouble before you pay.

When two vendors look similar on the surface, the one that publishes a recent, lot-specific certificate is the safer choice. Proof on paper beats a confident sales pitch every time.

Retatrutide Price Guide: What 10mg and 20mg Cost

Retatrutide was usually listed in 2026 from about $120 to $165 or more per vial, with 10 mg and 20 mg the common sizes. Bulk orders cost more in total but less per milligram. A price far below this range is a warning sign, not a deal.

These are ranges seen across research-supply listings in 2026, not a quote from any single vendor. Always add shipping on top, and weigh the price against the lab data. The FDA notes that suspiciously cheap drugs are often counterfeit.

Higher prices usually pay for third-party testing, COA paperwork, and US synthesis. A very cheap vial often skips those steps, so the lowest price is rarely the best value.

It is also worth comparing the price per milligram, not just the sticker price. A 30mg vial can look more expensive yet work out cheaper for the same amount of peptide. Match the price to the strength and the lab data together.

Retatrutide Safety in a Research Context

The honest answer on safety is that retatrutide’s safety in people is not established because it is still investigational. The published trial reported its findings, but the compound has not been approved for human use. Anyone handling it should treat it strictly as research material.

In a lab setting, safety mostly means careful handling. That includes clear research-use-only labeling, correct cold storage, and no human use. Approved metabolic drugs carry detailed safety leaflets on databases like DailyMed, but retatrutide does not, precisely because it is not approved.

It is also worth being honest about what is not known. Long-term effects on people have not been established, and the trials are still running. For a research buyer, the safe approach is simple: handle the material as a lab compound and never as a supplement.

• Status: Investigational.
• Approved leaflet: None.
• Lab rule: Handle as research-use-only.

Frequently Asked Questions

Is retatrutide the same as Mounjaro or Tirzepatide?

No, they are different molecules with different legal statuses. Retatrutide targets three receptors (GIP, GLP-1, and glucagon), whereas Tirzepatide, sold as Mounjaro, targets only two. Retatrutide is still investigational and is not an approved medicine, while Tirzepatide is already approved.

Is retatrutide a steroid or a SARM?

No, Retatrutide is a peptide, a short chain of amino acids that mimics natural hormone signals. Steroids and SARMs are completely different types of compounds that work in other ways. People sometimes lump them together only because all three are often sold for research, not because they are related.

What is GLP-3 RT, and is it the same as retatrutide?

GLP-3 RT is a vendor product name for research-grade retatrutide. Some suppliers, including Kylo Peptides, label it this way because retatrutide behaves like a triple-agonist peptide. It is the same research compound, supplied as a lyophilized powder for laboratory use.

Can I import retatrutide from an overseas vendor?

You can, but it adds risk. Overseas shipments can face customs delays, and the lab paperwork is harder to verify from abroad. Many researchers prefer a domestic vendor that publishes a per-batch certificate of analysis, since proof of purity matters more than a small saving.

How long does retatrutide last once it is mixed?

The dry, unopened powder lasts the longest, especially when kept frozen. Once a research solution is mixed, it is kept refrigerated and used within a shorter window that depends on the lab’s protocol. Exact stability varies, so follow the vendor’s guidance and your own laboratory standards.

When might retatrutide be approved?

There is no set date. Retatrutide is in late-stage trials, and approval would only come after those finish and a regulator reviews the full results. Until then, it stays investigational and is sold only as a research compound, not as a medicine.

Is research-grade retatrutide safe to handle in a lab?

When handled as a lab compound, the main safety steps are correct labeling, cold storage, and no human use. Its safety in people has not been established because it is still investigational and not approved as a medicine. Treat any claim about human safety or benefits with caution.

Final Thoughts on Buying Retatrutide for Research

Retatrutide peptide for sale is easy to find, but quality is not guaranteed, so the lab paperwork is often more important than the price. Retatrutide is investigational and sold for laboratory research use only, never for human use. For a clearly labeled, lab-tested source, Kylo Peptides was our top research-grade pick.

Before you buy reta from any vendor for research, read the current certificate of analysis. Then visit the source whose lab data you can actually verify.

Research-use-only notice: All products discussed here are sold for laboratory and research use only. They are not for human or veterinary use, and they are not approved by the FDA for any medical purpose. Retatrutide (LY3437943) is an investigational compound. Nothing here is medical advice or an endorsement of human use. Always follow the laws and institutional rules that apply to handling research compounds.

Related posts:

Other Imaging Techniques in Dilated Cardiomyopathy Basic Echocardiography in Arrhythmogenic Right Ventricular Cardiomyopathy How Often Do You Really Need Dental X-Rays? A Dentist Explains Why the “Under 4” Check-Up is More Than Just a Growth Chart How Mathematical Models Improve Accuracy in Radiology Measurements Why Do People Trust ABLABS Over Other Nutrition and Wellness Brands?

Stay updated, free articles. Join our Telegram channel

Join